Výsledky vyhledávání

Potential life years not saved due to lack of access to anti-EGFR tyrosine kinase inhibitors for lung cancer treatment in the Brazilian public healthcare system: Budget impact and... Autor Aguiar Júnior, Pedro, Barreto, Carmelia Maria Noia, Roitberg, Felipe, Lopes Júnior, Gilberto, del Giglio, Auro

Získat plný text

Non-invasive approaches to monitor EGFR-TKI treatment in non-small-cell lung cancer Autor Wei Sun, Xun Yuan, Yijun Tian, Hua Wu, Hanxiao Xu, Guoqing Hu, Kongming Wu

Získat plný text Získat plný text

Use of the Epidermal Growth Factor Receptor Inhibitors Gefitinib, Erlotinib, Afatinib, Dacomitinib, and Icotinib in the Treatment of Non-Small-Cell Lung Cancer: A Systematic Review Autor Peter Ellis, N. Coakley, Ronald Feld, S. Kuruvilla, Yee Ung

Získat plný text Získat plný text

Combining AKT inhibition with chloroquine and gefitinib prevents compensatory autophagy and induces cell death in EGFR mutated NSCLC cells Autor Sivan Bokobza, Yanyan Jiang, Anika M. Weber, Aoife Devery, Anderson J. Ryan

Získat plný text Získat plný text

Cost‐effectiveness of epidermal growth factor receptor mutation testing and first‐line treatment with gefitinib for patients with advanced adenocarcinoma of the lung Autor Gilberto Lopes, Joel E. Segel, Daniel S.W. Tan, Kate Young, Tony Mok, Eric Finkelstein

Získat plný text Získat plný text

Hepatic myofibroblasts promote the progression of human cholangiocarcinoma through activation of epidermal growth factor receptor Autor Audrey Clapéron, Martine Mergey, Lynda Aoudjehane, Thanh Huong Nguyen Ho-Bouldoires, Dominique Wendum, Aurélie Prignon, Fatiha Merabtene, Delphine Firrincieli, Christèle Desbois‐Mouthon, Olivier Scatton, Filoména Conti, Chantal Housset, Laura Fouassier

Získat plný text Získat plný text

MiR-200c overexpression is associated with better efficacy of EGFR-TKIs in non-small cell lung cancer patients with EGFR wild-type Autor Jiayu Li, Xuefei Li, Shengxiang Ren, Xiaoxia Chen, Yishi Zhang, Fei Zhou, Mingchuan Zhao, Chao Zhao, Xiu Chen, Ningning Cheng, Yinmin Zhao, Caicun Zhou, Fred R. Hirsch

Získat plný text Získat plný text

Afatinib induces apoptosis in NSCLC without EGFR mutation through Elk-1-mediated suppression of CIP2A Autor Ting-Ting Chao, Cheng‐Yi Wang, Yen‐Lin Chen, Chih‐Cheng Lai, Fang-Yu Chang, Yi‐Ting Tsai, Chung-Hao H. Chao, Chung-Wai Shiau, Yuh-Chin T. Huang, Chong‐Jen Yu, Kuen‐Feng Chen

Získat plný text Získat plný text

Novel Gefitinib Formulation with Improved Oral Bioavailability in Treatment of A431 Skin Carcinoma Autor Chandraiah Godugu, Ravi Doddapaneni, Apurva R. Patel, Rakesh K. Singh, Roger S. Mercer, Mandip Singh

Získat plný text

Clinical Implications of KRAS Mutations in Lung Cancer Patients Treated with Tyrosine Kinase Inhibitors: An Important Role for Mutations in Minor Clones Autor Antonio Marchetti, Michèle Milella, Lara Felicioni, Federico Cappuzzo, Luciana Irtelli, Maela Del Grammastro, Mariagrazia Sciarrotta, Sara Malatesta, Carmen Nuzzo, Giovanna Finocchiaro, Bruno Perrucci, Donatella Carlone, Alain Gelibter, Anna Ceribelli, Andrea Mezzetti, Stefano Iacobelli, Francesco Cognetti, Fiamma Buttitta

Získat plný text

Epidermal growth factor receptor‐targeted therapy in locally advanced or metastatic squamous cell carcinoma of the penis Autor Bradley Curtis Carthon, Chaan S. Ng, Curtis A. Pettaway, Lance C. Pagliaro

Získat plný text

Inhibition of IGF1R signaling abrogates resistance to afatinib (BIBW2992) in EGFR T790M mutant lung cancer cells Autor Yongik Lee, Yian Wang, Michael A. James, Joseph H. Jeong, Ming You

Získat plný text

Involvement of epidermal growth factor receptor overexpression in the promotion of breast cancer brain metastasis Autor Fang Nie, Jian Yang, Song Wen, Yanli An, Jie Ding, Shenghong Ju, Zhen Zhao, Hua‐Jun Chen, Xin‐Gui Peng, Stephen T.C. Wong, Hong Zhao, Gao‐Jun Teng

Získat plný text Získat plný text

Anti-HER3 monoclonal antibody patritumab sensitizes refractory non-small cell lung cancer to the epidermal growth factor receptor inhibitor erlotinib Autor Kimio Yonesaka, Kenji Hirotani, Hisato Kawakami, Masayuki Takeda, Hiroyasu Kaneda, Kazuko Sakai, Isamu Okamoto, Kazuto Nishio, Pasi A. Jänne, Kazuhiko Nakagawa

Získat plný text

Inhibition of insulin-like growth factor-1 receptor signaling enhances growth-inhibitory and proapoptotic effects of gefitinib (Iressa) in human breast cancer cells Autor Anne Camirand, Mahvash Zakikhani, Fiona B. Young, Michaël Pollak

Získat plný text Získat plný text

Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790M Autor Kenneth S. Thress, Cloud P. Paweletz, Enriqueta Felip, Byoung Chul Cho, Daniel Stetson, Brian Dougherty, Zhongwu Lai, Aleksandra Markovets, Ana Vivancos, Yanan Kuang, Dalia Ercan, Sarah E Matthews, Mireille Cantarini, J. Carl Barrett, Pasi A. Jänne, Geoffrey R. Oxnard

Získat plný text

Effect of sialylation on EGFR phosphorylation and resistance to tyrosine kinase inhibition Autor Hsin‐Yung Yen, Ying-Chih Liu, Nai-Yu Chen, Chia‐Feng Tsai, Yi‐Ting Wang, Yu‐Ju Chen, Tsui-Ling Hsu, Pan‐Chyr Yang, Chi‐Huey Wong

Získat plný text Získat plný text

Fasting potentiates the anticancer activity of tyrosine kinase inhibitors by strengthening MAPK signaling inhibition Autor Irene Caffa, Vito D’Agostino, Patrizia Damonte, Debora Soncini, Michele Cea, Fiammetta Monacelli, Patrizio Odetti, Alberto Ballestrero, Alessandro Provenzani, Valter D. Longo, Alessio Nencioni

Získat plný text Získat plný text

Reciprocal positive regulation between Cx26 and PI3K/Akt pathway confers acquired gefitinib resistance in NSCLC cells via GJIC-independent induction of EMT Autor Jie Yang, Gang Qin, Moulun Luo, Jiangyuan Chen, Q Zhang, L Li, Ling Pan, Shanyu Qin

Získat plný text Získat plný text

Epidermal Growth Factor Receptor Mutations in Patients with Non–Small Cell Lung Cancer Autor Bruce E. Johnson, Pasi A. Jänne

Získat plný text Získat plný text